Monday, July 09, 2018 3:15:54 PM
Glad out, in one trade just lost ~7.5% and now a days worth of volume is @ 2.50 ask.
SNOA
SNOA
Recent SNOA News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 09:00:19 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 04/27/2026 10:00:31 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/25/2026 01:21:53 AM
- Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering • ACCESS Newswire • 04/24/2026 01:21:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/24/2026 04:15:24 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 09:23:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 12:30:09 PM
- Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart • ACCESS Newswire • 03/24/2026 12:30:00 PM
- Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin • ACCESS Newswire • 03/18/2026 12:30:00 PM
- Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results • ACCESS Newswire • 02/10/2026 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/10/2026 09:01:52 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 10:00:02 PM
- Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development • ACCESS Newswire • 01/28/2026 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 09:01:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:30:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:25:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:24:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:22:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:21:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:18:48 PM
- National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced • ACCESS Newswire • 11/13/2025 01:30:00 PM
- Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf • ACCESS Newswire • 11/06/2025 09:01:00 PM
- Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results • ACCESS Newswire • 11/04/2025 01:56:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2025 01:46:09 PM
